Effects of the antiestrogen tamoxiten on low-density lipoprotein concentrations and oxidation in postmenopausal women

The American Journal of Cardiology

Volumn 76, Issue 14, 1995, Pages 1072-1073

  Guetta, Victor ^a   Lush, Richard M ^a   Figg, William D ^a   Waclawiw, Myron A ^a   Cannon III, Richard O ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TAMOXIFEN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; LIPOPROTEINS, LDL; MIDDLE AGED; OXIDATION-REDUCTION; POSTMENOPAUSE; TAMOXIFEN;

EID: 0028807884     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)80302-6     Document Type: Article

References (5)

1. Fatal Myocardial Infarction in the Scottish Adjuvant Tamoxifen Trial
2. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women
3. Protective action of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoprotein: a mechanism accounting for the cardioprotective action of tamoxifen?
4. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
5. Oestrogen and inhibition of oxidation of low-density lipoprotein in postmenopausal women